|
RESPIVAC TRT
|
-
|
EU/2/24/314/003
|
Laboratorios Hipra S.A., Spānija
|
QI01AD01
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for oculonasal suspension/use in drinking water
|
| International name (active substance): |
Turkey rhinotracheitis virus, strain 1062, Live
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
30-May-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/314/003 |
|
1 |
Stikla flakons, 5000 devas/flakonā |
-
|
|
|
Inflacam
|
5 mg/ml
|
EU/2/11/134/019
|
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
QM01AC06
|
cattle; pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
| Date of authorisation/renewal: |
09-Nov-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/11/134/019 |
5 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
|
|
FRONTPRO
|
136 mg
|
EU/2/19/240/016
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP53BE01
|
Dogs >25–50 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Afoxolaner
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
20-May-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/240/016 |
136 mg |
15 |
PVH/Aclar/Al blisteris, 1 tablete |
-
|
|
|
Locatim
|
-
|
EU/2/99/011/005
|
Melchior Sante Animale, Francija
|
QI02AT01
|
newborn calves
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for oral use
|
| International name (active substance): |
-
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
MERIAL Laboratoire Porte des Alpes, Francija
|
| Date of authorisation/renewal: |
28-Apr-2004
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/99/011/005 |
|
48 |
Stikla pudele, 60 ml |
-
|
|
|
EVICTO
|
45 mg
|
EU/2/19/242/004
|
VIRBAC, Francija
|
QP54AA05
|
cats 2,6 - 7,5 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Selamectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
VIRBAC, Francija
|
| Date of authorisation/renewal: |
19-Jul-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/242/004 |
60 mg/ml |
1 |
Polipropilēna pipete, 0,75 ml |
-
|
|
|
Advocate Spot-on lieliem kaķiem
|
-
|
EU/2/03/039/038
|
Bayer Animal Health , Vācija
|
QP54AB52
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Imidacloprid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
16-Jul-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/039/038 |
|
12 |
Pipete, 0,8 ml |
-
|
|
|
Biocan Novel DHPPi/L4R
|
-
|
V/I/25/0017
|
Bioveta, a.s., Čehija
|
QI07AJ06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and suspension for suspension for injection
|
| International name (active substance): |
Canine Distemper virus, strain CDV Bio 11/A, Canine Adenovirus Type 2, strain CAV2-Bio 13, Canine Parvovirus Type 2, strain CPV-2b-Bio 12/B, Canine Parainfluenza virus, strain CPiV2-Bio15, Inactivated rabies virus, strain SAD Vnukovo-32, Leptospira interrogans serovar Bratislava, strain MSLB 1088, Leptospira kirschneri serovar Grippotyphosa, strain MSLB 1091, Inactivated Leptospira interrogans serovar Canicola, strain MSLB 1090, Leptospira interrogans serovar Icterohaemorrhagia, strain MSLB 1089
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
20-Mar-2025
|
| Marketing authorisation valid until: |
19-Mar-2030
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 20032025LI (16-Mar-2026)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/25/0017-01 |
|
25 |
Stikla flakons, 1 deva |
[PDF]
|
|
|
Nobivac Myxo-RHD Plus
|
-
|
EU/2/19/244/002
|
Intervet International BV, Nīderlande
|
QI08AD
|
rabbits
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Live myxoma vectored RHD virus strain 009, Live myxoma vectored RHD virus strain MK1899
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
19-Nov-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/244/002 |
|
25 |
Stikla flakons, 1 deva |
-
|
|
|
Easotic
|
-
|
EU/2/08/085/004
|
Virbac S.A., Francija
|
QS02CA91
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
ear drops, suspension
|
| International name (active substance): |
Gentamicin,Hydrocortisone aceponate,Miconazole
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Virbac S.A., Francija
|
| Date of authorisation/renewal: |
11-Nov-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/085/004 |
|
50 |
Plastmasas pipete, 1 deva |
-
|
|
|
Bravecto
|
112.5 mg
|
EU/2/13/158/019
|
Intervet International B.V., Nīderlande
|
QP53B
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet UK Ltd, Lielbritānija
|
| Date of authorisation/renewal: |
13-Feb-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/158/019 |
112,5 mg |
2 |
Pipete, 1 deva |
-
|
|
|
Ceperolon
|
10 mg
|
EU/2/24/321/002
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QC03DA01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Spironolactone
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
12-Sep-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/321/002 |
10 mg |
3 |
Al/OPA/Al/PVH blisteris, 10 tablete |
-
|
|
|
Coxatab
|
100 mg
|
EU/2/22/286/017
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
| Date of authorisation/renewal: |
12-Aug-2022
|
| Marketing authorisation valid until: |
11-Aug-2027
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/22/286/017 |
100 mg/tabl. |
1 |
alumīnija/PVC/PE/PVDC blisteris, 100 tablete |
-
|
|
|
LYDAXX
|
100 mg/ml
|
EU/2/20/253/003
|
Vetoquinol S.A., Francija
|
QJ01FA94
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Tulathromycin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
18-May-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/253/003 |
|
1 |
Stikla flakons, 250 ml |
-
|
|
|
Syvazul BTV 3
|
-
|
EU/2/24/332/001
|
LABORATORIOS SYVA S.A., Spānija
|
QI04AA02
|
sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Bluetongue virus, serotype 3 (BTV-3), strain BTV-3/NET2023, inactivated
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
20-Feb-2025
|
| Marketing authorisation valid until: |
19-Feb-2026
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/332/001 |
|
1 |
Polipropilēna flakons, 80 ml |
-
|
|
|
Librela
|
20 mg
|
EU/2/20/261/011
|
Zoetis Belgium S.A., Beļģija
|
QN02BG91
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Bedinvetmab
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
10-Nov-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/261/011 |
20 mg |
2 |
Stikla flakons, 1 ml |
-
|
|
|
Fluralaner Intervet
|
560 mg
|
EU/2/25/346/018
|
Intervet International B.V., Nīderlande
|
QP53BE02
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
27-Jun-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/346/018 |
|
1 |
Blisteris, 2 tablete |
-
|
|
|
Rabigen SAG2
|
-
|
EU/2/00/021/001
|
Virbac S.A., Francija
|
QI07BD
|
foxes
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Attenuated live rabies virus
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Virbac S.A., Francija
|
| Date of authorisation/renewal: |
16-Mar-2005
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/00/021/001 |
|
200 |
Trauciņš, 200 deva |
-
|
|
|
APOQUEL
|
5.4 mg
|
EU/2/13/154/004
|
Zoetis Belgium S.A., Beļģija
|
QD11AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
film-coated tablets
|
| International name (active substance): |
Oclacitinib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Pfizer Italia S.R.L., Itālija
|
| Date of authorisation/renewal: |
26-Jul-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/154/004 |
|
1 |
Blisteris, 100 tablete |
-
|
|
|
Porcilis PCV M Hyo
|
-
|
EU/2/14/175/009
|
Intervet International B.V., Nīderlande
|
QI09AL
|
fattening pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated Mycoplasma hyopneumoniae,Inactivated recombinant Porcine Circovirus type 2
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
30-Nov-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/175/009 |
|
10 |
PET pudele, 100 deva |
-
|
|
|
Evanovo
|
-
|
EU/2/22/284/003
|
Laboratorios Hipra S.A., Spānija
|
QI01AN01
|
embryonated chicken eggs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension and solvent for suspension for injection
|
| International name (active substance): |
Eimeria acervulina, strain 044, Eimeria maxima, strain 013, Eimeria praecox, strain 007, Eimeria tenella, strain 004
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
27-Jul-2022
|
| Marketing authorisation valid until: |
26-Jul-2027
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/22/284/003 |
|
1 |
Stikla flakons, 4000 deva |
-
|
|